A compounded medication is a customized preparation made by licensed pharmacists to meet a patient’s unique therapeutic needs. This may include adjusting dosage strengths, removing allergens, modifying dosage forms, or creating formulations not commercially available. All compounding at AscendRx follows established standards such as USP <795> for non-sterile and USP <797> for sterile preparations.

Doctors prescribe compounded medications when standard, commercially available products do not fully meet patient-specific needs.

Typical reasons include:
• Personalized or micro-dosing requirements
• Allergy-free or preservative-free alternatives
• Pediatric or geriatric dosage adjustments
• Bio-identical hormone and nutritional therapies
• Addressing drug shortages or discontinued products

Your doctor chooses compounding to ensure you receive the most suitable therapy for your condition.

AIX follows a 48-hour lead time for most compounded prescriptions, consistent with AIP’s established service standards. Certain formulations—such as sterile preparations, specialized hormones, or items requiring extended verification—may take slightly longer. Our team will keep you updated if more time is needed.

Yes. AIX provides nationwide delivery, including temperature-controlled logistics for medicines requiring cold-chain management. Delivery coordination and status updates are provided to ensure safe and timely receipt of your medication.

Yes—when prepared by qualified pharmacists using compliant facilities, quality systems, and validated materials.

At AIX, safety and quality are upheld through:
• Compliance with USP <795>, <797>, and <800>
• Adherence to applicable Philippine FDA compounding requirements
• Controlled environments and documented preparation processes
• USP-grade active ingredients sourced from GMP-compliant manufacturers
• Regular third-party laboratory testing with SGS Philippines to verify identity, purity, and quality of raw materials

Every compounded prescription undergoes thorough checks for accuracy, sterility (when applicable), documentation integrity, and proper labeling.

References
• United States Pharmacopeia (USP) Chapters <795>, <797>, <800>
• Philippine FDA Administrative Orders & Compounding Framework (e.g., AO 55 s. 2021)
• International cGMP-aligned quality assurance standards